PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20418897-0	2010	Glycyrrhetinic acid inhibits ICAM-1 expression via blocking JNK and NF-kappaB pathways in TNF-alpha-activated endothelial cells.	Glycyrrhetinic Acid	0-19	nuclear factor kappa B subunit 1	Homo sapiens	68-77	
20418897-8	2010	Furthermore, GA apparently inhibited I kappaB/NF-kappaB signaling system by preventing I kappaB degradation, NF-kappaB translocation, and NF-kappaB/DNA binding activity.	Glycyrrhetinic Acid	13-15	nuclear factor kappa B subunit 1	Homo sapiens	46-55	
20418897-8	2010	Furthermore, GA apparently inhibited I kappaB/NF-kappaB signaling system by preventing I kappaB degradation, NF-kappaB translocation, and NF-kappaB/DNA binding activity.	Glycyrrhetinic Acid	13-15	nuclear factor kappa B subunit 1	Homo sapiens	109-118	
20418897-8	2010	Furthermore, GA apparently inhibited I kappaB/NF-kappaB signaling system by preventing I kappaB degradation, NF-kappaB translocation, and NF-kappaB/DNA binding activity.	Glycyrrhetinic Acid	13-15	nuclear factor kappa B subunit 1	Homo sapiens	109-118	
20418897-9	2010	Finally, pretreatment with GA or the inhibitors of NF-kappaB, JNK, and p38 reduced the ICAM-1 protein expression induced by TNF-alpha.	Glycyrrhetinic Acid	27-29	nuclear factor kappa B subunit 1	Homo sapiens	51-60	
20418897-11	2010	This inhibition is attributed to GA interruption of both JNK/c-Jun and I kappaB/NF-kappaB signaling pathways, which decrease activator protein-1 (AP-1) and NF-kappaB mediated ICAM-1 expressions.	Glycyrrhetinic Acid	33-35	nuclear factor kappa B subunit 1	Homo sapiens	80-89	
20418897-11	2010	This inhibition is attributed to GA interruption of both JNK/c-Jun and I kappaB/NF-kappaB signaling pathways, which decrease activator protein-1 (AP-1) and NF-kappaB mediated ICAM-1 expressions.	Glycyrrhetinic Acid	33-35	nuclear factor kappa B subunit 1	Homo sapiens	156-165	
33634641-0	2020	[Glycyrrhetinic acid inhibits proliferation of osteosarcoma cell line MG63 by inhibiting NF-kappaB signaling pathway].	Glycyrrhetinic Acid	1-20	nuclear factor kappa B subunit 1	Homo sapiens	89-98	
31191251-2	2019	Glycyrrhetic acid (GA), a compound isolated from licorice (Glycyrrhiza glabra), has been shown to decrease cell viability and increases apoptosis in human cancer cell lines by NF-kappaB signaling pathway suppression.	Glycyrrhetinic Acid	0-17	nuclear factor kappa B subunit 1	Homo sapiens	176-185	
31191251-2	2019	Glycyrrhetic acid (GA), a compound isolated from licorice (Glycyrrhiza glabra), has been shown to decrease cell viability and increases apoptosis in human cancer cell lines by NF-kappaB signaling pathway suppression.	Glycyrrhetinic Acid	19-21	nuclear factor kappa B subunit 1	Homo sapiens	176-185	
30528976-0	2018	Glycyrrhetinic acid derivatives containing aminophosphonate ester species as multidrug resistance reversers that block the NF-kappaB pathway and cell proliferation.	Glycyrrhetinic Acid	0-19	nuclear factor kappa B subunit 1	Homo sapiens	123-132	
30528976-1	2018	Novel NF-kappaB inhibitors based on Glycyrrhetinic acid (GA) derivatives containing aminophosphonate ester moieties were rationally designed and synthesized as well as evaluated their antitumor activities using MTT assay.	Glycyrrhetinic Acid	36-55	nuclear factor kappa B subunit 1	Homo sapiens	6-15	
30528976-1	2018	Novel NF-kappaB inhibitors based on Glycyrrhetinic acid (GA) derivatives containing aminophosphonate ester moieties were rationally designed and synthesized as well as evaluated their antitumor activities using MTT assay.	Glycyrrhetinic Acid	57-59	nuclear factor kappa B subunit 1	Homo sapiens	6-15